These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 25645916

  • 1. The BRCA1 tumor suppressor binds to inositol 1,4,5-trisphosphate receptors to stimulate apoptotic calcium release.
    Hedgepeth SC, Garcia MI, Wagner LE, Rodriguez AM, Chintapalli SV, Snyder RR, Hankins GD, Henderson BR, Brodie KM, Yule DI, van Rossum DB, Boehning D.
    J Biol Chem; 2015 Mar 13; 290(11):7304-13. PubMed ID: 25645916
    [Abstract] [Full Text] [Related]

  • 2. The Bcl-2 protein family member Bok binds to the coupling domain of inositol 1,4,5-trisphosphate receptors and protects them from proteolytic cleavage.
    Schulman JJ, Wright FA, Kaufmann T, Wojcikiewicz RJH.
    J Biol Chem; 2013 Aug 30; 288(35):25340-25349. PubMed ID: 23884412
    [Abstract] [Full Text] [Related]

  • 3. Remodeling of Ca2+ signaling in cancer: Regulation of inositol 1,4,5-trisphosphate receptors through oncogenes and tumor suppressors.
    Ando H, Kawaai K, Bonneau B, Mikoshiba K.
    Adv Biol Regul; 2018 May 30; 68():64-76. PubMed ID: 29287955
    [Abstract] [Full Text] [Related]

  • 4. Inositol 1,4,5-trisphosphate receptor-isoform diversity in cell death and survival.
    Ivanova H, Vervliet T, Missiaen L, Parys JB, De Smedt H, Bultynck G.
    Biochim Biophys Acta; 2014 Oct 30; 1843(10):2164-83. PubMed ID: 24642269
    [Abstract] [Full Text] [Related]

  • 5. A dual role for the anti-apoptotic Bcl-2 protein in cancer: mitochondria versus endoplasmic reticulum.
    Akl H, Vervloessem T, Kiviluoto S, Bittremieux M, Parys JB, De Smedt H, Bultynck G.
    Biochim Biophys Acta; 2014 Oct 30; 1843(10):2240-52. PubMed ID: 24768714
    [Abstract] [Full Text] [Related]

  • 6. Targeting Bcl-2-IP3 receptor interaction to treat cancer: A novel approach inspired by nearly a century treating cancer with adrenal corticosteroid hormones.
    Distelhorst CW.
    Biochim Biophys Acta Mol Cell Res; 2018 Nov 30; 1865(11 Pt B):1795-1804. PubMed ID: 30053503
    [Abstract] [Full Text] [Related]

  • 7. IP3 Receptor Biology and Endoplasmic Reticulum Calcium Dynamics in Cancer.
    Parys JB, Bultynck G, Vervliet T.
    Prog Mol Subcell Biol; 2021 Nov 30; 59():215-237. PubMed ID: 34050869
    [Abstract] [Full Text] [Related]

  • 8. 80K-H interacts with inositol 1,4,5-trisphosphate (IP3) receptors and regulates IP3-induced calcium release activity.
    Kawaai K, Hisatsune C, Kuroda Y, Mizutani A, Tashiro T, Mikoshiba K.
    J Biol Chem; 2009 Jan 02; 284(1):372-380. PubMed ID: 18990696
    [Abstract] [Full Text] [Related]

  • 9. Regulatory Mechanisms of Endoplasmic Reticulum Resident IP3 Receptors.
    Shah SZA, Zhao D, Khan SH, Yang L.
    J Mol Neurosci; 2015 Aug 02; 56(4):938-948. PubMed ID: 25859934
    [Abstract] [Full Text] [Related]

  • 10. Isoform- and species-specific control of inositol 1,4,5-trisphosphate (IP3) receptors by reactive oxygen species.
    Bánsághi S, Golenár T, Madesh M, Csordás G, RamachandraRao S, Sharma K, Yule DI, Joseph SK, Hajnóczky G.
    J Biol Chem; 2014 Mar 21; 289(12):8170-81. PubMed ID: 24469450
    [Abstract] [Full Text] [Related]

  • 11. Altered Ca(2+) signaling in cancer cells: proto-oncogenes and tumor suppressors targeting IP3 receptors.
    Akl H, Bultynck G.
    Biochim Biophys Acta; 2013 Apr 21; 1835(2):180-93. PubMed ID: 23232185
    [Abstract] [Full Text] [Related]

  • 12. IP3 receptors - lessons from analyses ex cellula.
    Rossi AM, Taylor CW.
    J Cell Sci; 2018 Dec 14; 132(4):. PubMed ID: 30552138
    [Abstract] [Full Text] [Related]

  • 13. Unique Regulatory Properties of Heterotetrameric Inositol 1,4,5-Trisphosphate Receptors Revealed by Studying Concatenated Receptor Constructs.
    Chandrasekhar R, Alzayady KJ, Wagner LE, Yule DI.
    J Biol Chem; 2016 Mar 04; 291(10):4846-60. PubMed ID: 26755721
    [Abstract] [Full Text] [Related]

  • 14. Astrocytic Ca2+ signaling mediated by the endoplasmic reticulum in health and disease.
    Okubo Y.
    J Pharmacol Sci; 2020 Oct 04; 144(2):83-88. PubMed ID: 32709559
    [Abstract] [Full Text] [Related]

  • 15. The type 2 inositol 1,4,5-trisphosphate receptor, emerging functions for an intriguing Ca²⁺-release channel.
    Vervloessem T, Yule DI, Bultynck G, Parys JB.
    Biochim Biophys Acta; 2015 Sep 04; 1853(9):1992-2005. PubMed ID: 25499268
    [Abstract] [Full Text] [Related]

  • 16. IP3 Receptor Properties and Function at Membrane Contact Sites.
    Roest G, La Rovere RM, Bultynck G, Parys JB.
    Adv Exp Med Biol; 2017 Sep 04; 981():149-178. PubMed ID: 29594861
    [Abstract] [Full Text] [Related]

  • 17. IP3 receptor isoforms differently regulate ER-mitochondrial contacts and local calcium transfer.
    Bartok A, Weaver D, Golenár T, Nichtova Z, Katona M, Bánsághi S, Alzayady KJ, Thomas VK, Ando H, Mikoshiba K, Joseph SK, Yule DI, Csordás G, Hajnóczky G.
    Nat Commun; 2019 Aug 19; 10(1):3726. PubMed ID: 31427578
    [Abstract] [Full Text] [Related]

  • 18. Type 3 IP3 receptors: The chameleon in cancer.
    Rosa N, Sneyers F, Parys JB, Bultynck G.
    Int Rev Cell Mol Biol; 2020 Aug 19; 351():101-148. PubMed ID: 32247578
    [Abstract] [Full Text] [Related]

  • 19. Requirement of inositol 1,4,5-trisphosphate receptors for tumor-mediated lymphocyte apoptosis.
    Steinmann C, Landsverk ML, Barral JM, Boehning D.
    J Biol Chem; 2008 May 16; 283(20):13506-9. PubMed ID: 18364356
    [Abstract] [Full Text] [Related]

  • 20. The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor.
    Rong YP, Bultynck G, Aromolaran AS, Zhong F, Parys JB, De Smedt H, Mignery GA, Roderick HL, Bootman MD, Distelhorst CW.
    Proc Natl Acad Sci U S A; 2009 Aug 25; 106(34):14397-402. PubMed ID: 19706527
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.